0RIS

Targovax Asa Notizie

Acquistare
Vendere
Le migliori offerte per accedere ai dati in tempo reale
Borsa di Londra
Sottoscrizione Mensile
per soli
22,17 €
Book Borsa di Londra
Sottoscrizione Mensile
per soli
59,13 €
World Guru
Sottoscrizione Mensile
per soli
126,50 €
Prezzi IVA esclusa
Nome Azione Simbolo Borsa Mercato Tipo
Targovax Asa 0RIS Londra Azione Ordinaria
  Variazione Variazione % Quotazione Attuale Ora
0,00 0,0% 15,98 02:00:00
Apertura Min Max Prezzo di chiusura Chiusura
15,98 15,98
quotazione »

Ultime notizie

Data Ora Fonte Titolo
01/7/202111:11PRNUSTargovax ASA appoints Dr Lone Ottesen as Chief Development..
01/7/202111:10PRNUSTargovax ASA appoints Dr Lone Ottesen as Chief Development..
28/6/202107:43PRNUSTargovax to present at the 4th Annual Next Gen..
28/6/202107:34PRNUSTargovax to present at the 4th Annual Next Gen..
10/6/202113:44PRNUSTargovax's ONCOS-102 mesothelioma 24-month data shows..
10/6/202113:42PRNUSTargovax's ONCOS-102 mesothelioma 24-month data shows..
21/5/202107:21PRNUSTargovax to present at upcoming investor and scientific..
21/5/202107:19PRNUSTargovax to present at upcoming investor and scientific..
06/5/202107:20PRNUSTargovax ASA: First quarter 2021 results
06/5/202107:18PRNUSTargovax ASA: First quarter 2021 results
04/3/202116:47PRNUSTargovax ASA: Registration of share capital increase..
04/3/202116:45PRNUSTargovax ASA: Registration of share capital increase..
01/3/202118:26PRNUSTargovax ASA: Exercise of options under LTI program and..
01/3/202118:24PRNUSTargovax ASA: Exercise of options under LTI program and..
23/2/202107:16PRNUSContinued survival benefit in Targovax's ONCOS-102 trial in..
18/2/202107:43PRNUSReminder: Invitation to Targovax's Capital Markets Day 18..
18/2/202107:39PRNUSReminder: Invitation to Targovax's Capital Markets Day 18..
15/2/202107:17PRNUSTargovax receives Fast-Track designation for ONCOS-102
15/2/202107:15PRNUSTargovax receives Fast-Track designation for ONCOS-102
11/2/202107:44PRNUSAgenda for Targovax's Capital Markets Day 18 February 2021
11/2/202107:42PRNUSAgenda for Targovax's Capital Markets Day 18 February 2021
10/2/202107:22PRNUSTargovax and Papyrus Therapeutics enter research..
10/2/202107:18PRNUSTargovax and Papyrus Therapeutics enter research..
06/1/202107:18PRNUSTargovax grants IOVaxis 3 months extension to the exclusive..
06/1/202107:15PRNUSTargovax grants IOVaxis 3 months extension to the exclusive..
15/12/202007:31PRNUSTargovax ASA: Save the date - Capital Markets Day 2021
15/12/202007:30PRNUSTargovax ASA: Save the date - Capital Markets Day 2021
02/12/202009:21PRNUSTargovax ASA: Invitation to online presentation at 10:00 CET..
02/12/202009:20PRNUSTargovax ASA: Invitation to online presentation at 10:00 CET..
02/12/202005:32PRNUSTargovax announces impressive objective responses as well as..
02/12/202005:30PRNUSTargovax announces impressive objective responses as well as..
24/11/202007:16PRNUSTargovax demonstrates encouraging survival data for..
24/11/202007:15PRNUSTargovax demonstrates encouraging survival data for..
17/11/202007:27PRNUSTargovax to present at Bryan Garnier & Co Virtual European..
09/11/202016:52PRNUSTargovax announces poster at the 2020 Society for..
05/11/202010:55PRNUSTargovax ASA: third quarter 2020 results
05/11/202007:37PRNUSTargovax ASA: third quarter 2020 results
28/10/202007:53PRNUSTargovax announces formation of new Scientific Advisory..
28/10/202007:51PRNUSTargovax announces formation of new Scientific Advisory..
19/10/202007:17PRNUSTargovax announces accepted abstract at SITC
19/10/202007:15PRNUSTargovax announces accepted abstract at SITC
13/10/202007:28PRNUSTargovax announces that the ONCOS-102 and durvalumab trial..
13/10/202007:24PRNUSTargovax announces that the ONCOS-102 and durvalumab trial..
12/10/202007:56PRNUSTargovax granted European Patent for ONCOS-102 in..
12/10/202007:51PRNUSTargovax granted European Patent for ONCOS-102 in..
Accedi alle altre notizie sul titolo »
La tua Cronologia
LSE
0RIS
Targovax A..
Registrati ora per visualizzare questi strumenti nella tua watchlist streaming.

Il Monitor ADVFN ti permette di visualizzare fino a 110 titoli ed è completamente gratuito.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

P: V: D:20210726 02:18:35